Alcohol BiPolar Disorder ADD ADHD
Mental and Physical Health Information
Olanzapine
Olanzapine
 | |
 | |
| Olanzapine | |
| Systematic (IUPAC) name | |
| 2-methyl-4-(4-methyl-1-piperazinyl)- 10H-thienobenzodiazepine | |
| Identifiers | |
| CAS number | 132539-06-1 |
| ATC code | N05AH03 |
| PubChem | 4585 |
| DrugBank | APRD00138 |
| Chemical data | |
| Formula | C17H20N4S |
| Mol. mass | 312.439 |
| SMILES | eMolecules & PubChem |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | 21–54 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | C |
| Legal status | Prescription only |
| Routes | oral, intramuscular |
Olanzapine (Zyprexa, Zyprexa Zydis, Zalasta, Zolafren, Olzapin, or in combination with fluoxetine Symbyax) is an atypical antipsychotic, approved by the FDA for the treatment of: schizophrenia on 1996-09-30; depressive episodes associated with bipolar disorder, as part of the Symbyax formulation, on 2003-12-24; acute manic episodes and maintenance treatment in bipolar disorder on 2004-01-14. Off-label uses are listed below.
The olanzapine formulations are manufactured and marketed by the pharmaceutical company Eli Lilly and Company, whose patent for olanzapine proper expires in 2011.
Even more about Olanzapine
Olanzapine
Olanzapine (Zyprexa, Zyprexa Zydis, or in combination with fluoxetine Symbyax) is an atypical antipsychotic, approved by the FDA for the treatment of: schizophrenia on 1996-09-30 ...
Olanzapine - Wikipedia, the free encyclopedia
Find Zyprexa (Olanzapine) medication description and FDA approved drug information including side effects, interactions and patient labeling.
